Common Contracts
7 similar Incentive Stock Option Agreement contracts by Altimmune, Inc., Solid Biosciences Inc.
Incentive Stock Option AgreementIncentive Stock Option Agreement • March 13th, 2019 • Solid Biosciences Inc. • Biological products, (no disgnostic substances) • Delaware
This Incentive Stock Option Award Agreement (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Solid Biosciences Inc., a Delaware corporation, (the “Company”) and the Participant specified above, pursuant to the Solid Biosciences Inc. 2018 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • November 9th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • November 9th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • September 28th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • September 28th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • September 28th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
THIS INCENTIVE STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Altimmune, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the Altimmune, Inc. 2017 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TO THE ALTIMMUNE, INC. 2017 OMNIBUS INCENTIVE PLANIncentive Stock Option Agreement • May 8th, 2017 • Altimmune, Inc. • Pharmaceutical preparations • Delaware
THIS INCENTIVE STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Altimmune, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the Altimmune, Inc. 2017 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
